01
BioCapZ Nanocapsid Platform
BioCapZ is a protein-based nanocapsid engineered at the quaternary-structure level for therapeutic and diagnostic delivery. Non-infectious and low-toxicity by design, it provides a modular chassis that can be tailored to each program — and each patient.
“From liposomes to AAVs to antibodies, these systems have largely been exhausted. We are building a new class of delivery platforms designed to overcome these limitations.”
“The future vaccine may not be a syringe, it could be something you drink, like a Coca-Cola.”
- Encapsulates DNA, mRNA, si-RNA, anti-sense RNA, proteins, and CRISPR gene-editing payloads
- Surface functionalization with therapeutic peptides for added targeting
- Ambient-temperature stable — no cold chain required, simplifying global logistics
- Engineered for mucosal delivery (oral/intranasal), enabling needle-free administration
- Multiple routes of administration — mucosal or conventional intravenous
- Survives the stomach environment — demonstrated oral delivery of CRISPR payloads in preclinical models
- Fully modular and personalizable to program or patient needs
